Drug Name |
Risedronic acid |
Drug ID |
BADD_D01950 |
Description |
Risedronic acid is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. It functions by preventing resorption of bone[FDA Label][A959]. |
Indications and Usage |
For the treatment of Paget's disease of the bone (osteitis deformans), postmenopausal and glucocorticoid-induced osteoporosis |
Marketing Status |
Prescription; Discontinued |
ATC Code |
M05BA07 |
DrugBank ID |
DB00884
|
KEGG ID |
D08484
|
MeSH ID |
D000068296
|
PubChem ID |
5245
|
TTD Drug ID |
D0PA5S
|
NDC Product Code |
Not Available |
Synonyms |
Risedronic Acid | 1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate | Atelvia | Risedronate Sodium | 2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate | 2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate | Risedronic Acid, Monosodium Salt | Actonel | Risedronate | Bisphosphonate Risedronate Sodium | Risedronate Sodium, Bisphosphonate | Sodium, Bisphosphonate Risedronate |